Somatic mutations in acquired pure red cell aplasia.
Clonal hematopoiesis
PRCA
STAT3
Somatic mutation
Journal
Seminars in hematology
ISSN: 1532-8686
Titre abrégé: Semin Hematol
Pays: United States
ID NLM: 0404514
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
received:
05
05
2022
revised:
28
06
2022
accepted:
08
07
2022
entrez:
17
9
2022
pubmed:
18
9
2022
medline:
21
9
2022
Statut:
ppublish
Résumé
Acquired pure red cell aplasia (PRCA) is a syndrome characterized by anemia and a marked reduction of erythroid progenitor cells with various etiologies. The 3 major subtypes of PRCA are idiopathic PRCA, large granular lymphocytic leukemia-associated PRCA and thymoma-associated PRCA, which are thought to be caused by a T-cell-mediated mechanism. In these 3 subtypes, an expansion of clonal cytotoxic T cells is often detected. In addition, those T cells recurrently harbor somatic mutations of STAT3, a gene coding one of the important signal transducers in the JAK/STAT system. Somatic mutations of clonal hematopoiesis (CH)-related genes, including epigenetic modifying genes, have also been reported, however, the data are still not mature enough upon which to draw conclusion, Somatic mutations of STAT3 and CH-related genes may be unique characteristics of acquired PRCA. However, their involvement in dyserythropoiesis or clinical relevance to the clinical course of those somatic mutations. Mutational landscapes, their involvements in dyserythropoiesis and clinical relevance in acquired PRCA remains unclear, and further investigation is needed.
Identifiants
pubmed: 36115689
pii: S0037-1963(22)00038-5
doi: 10.1053/j.seminhematol.2022.07.001
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
131-136Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.